News on Inbios srl from BioPortfolio.com http://www.BioPortfolio.com Consolidated Inbios srl news from BioPortfolio.com Wed, 10 Feb 2010 03:30:35 GMT en SeraCare Reports First Quarter Fiscal Year 2010 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035404&HITNO=0&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035404&THISHREF=http://c.moreover.com/click/here.pl%3fz2536228970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035404&HITNO=0&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035404&THISHREF=http://c.moreover.com/click/here.pl%3fz2536228970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Study suggests environmental factors play a significant role in the etiology of Crohn's diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024678&HITNO=1&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024678&THISHREF=http://c.moreover.com/click/here.pl%3fz2529056064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024678&HITNO=1&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024678&THISHREF=http://c.moreover.com/click/here.pl%3fz2529056064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: New market research report on special purpose needleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987160&HITNO=2&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987160&THISHREF=http://c.moreover.com/click/here.pl%3fz2509635932%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987160&HITNO=2&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987160&THISHREF=http://c.moreover.com/click/here.pl%3fz2509635932%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: DHMC patient surveillance system decreases adverse events in postoperative carehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952582&HITNO=3&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952582&THISHREF=http://c.moreover.com/click/here.pl%3fz2490887440%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952582&HITNO=3&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952582&THISHREF=http://c.moreover.com/click/here.pl%3fz2490887440%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Mechanism of Entecavir Resistance of Hepatitis B Virus with Viral Breakthrough as Determined by Long-Term Clinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952391&HITNO=4&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952391&THISHREF=http://c.moreover.com/click/here.pl%3fz2490774777%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952391&HITNO=4&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952391&THISHREF=http://c.moreover.com/click/here.pl%3fz2490774777%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAAC: In Vitro Resistance Selection Studies of RLP068/Cl, a New Zn(II) Phthalocyanine Suitable for Antimicrobial Phohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952414&HITNO=5&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952414&THISHREF=http://c.moreover.com/click/here.pl%3fz2490778101%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952414&HITNO=5&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952414&THISHREF=http://c.moreover.com/click/here.pl%3fz2490778101%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAAC: Health Canada approves Novartis' Afinitor to treat patients with mRCChttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934243&HITNO=6&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934243&THISHREF=http://c.moreover.com/click/here.pl%3fz2482123443%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934243&HITNO=6&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934243&THISHREF=http://c.moreover.com/click/here.pl%3fz2482123443%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Phase-III study of Revlimid by Intergroupe Francophone du Myelome & University Hospital of Toulouse meets primhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912601&HITNO=7&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912601&THISHREF=http://c.moreover.com/click/here.pl%3fz2470295817%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912601&HITNO=7&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912601&THISHREF=http://c.moreover.com/click/here.pl%3fz2470295817%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Anaemia, microcytosis and sirolimusis iron the missing linkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906489&HITNO=8&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906489&THISHREF=http://c.moreover.com/click/here.pl%3fz2466942875%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906489&HITNO=8&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906489&THISHREF=http://c.moreover.com/click/here.pl%3fz2466942875%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: MedGenesis Announces Agreements With Amgen and Biovailhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907399&HITNO=9&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907399&THISHREF=http://c.moreover.com/click/here.pl%3fz2467411471%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907399&HITNO=9&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907399&THISHREF=http://c.moreover.com/click/here.pl%3fz2467411471%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: MedGenesis enters agreements with Amgen and Biovailhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907226&HITNO=10&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907226&THISHREF=http://c.moreover.com/click/here.pl%3fz2467344806%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907226&HITNO=10&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907226&THISHREF=http://c.moreover.com/click/here.pl%3fz2467344806%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Giant A&D Pharma taps into private clinics markethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905700&HITNO=11&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905700&THISHREF=http://c.moreover.com/click/here.pl%3fz2466426100%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905700&HITNO=11&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905700&THISHREF=http://c.moreover.com/click/here.pl%3fz2466426100%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZiarul Financiar: News and FDA Updates for Alcon (NYSE:ACL), Biogen (NASDAQ:BIIB), Celgene (NASDAQ:CELG)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904940&HITNO=12&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904940&THISHREF=http://c.moreover.com/click/here.pl%3fz2465930684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904940&HITNO=12&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904940&THISHREF=http://c.moreover.com/click/here.pl%3fz2465930684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCalifornia Chronicle: News and FDA Updates for Alcon (NYSE:ACL), Biogen (NASDAQ:BIIB), Celgene (NASDAQ:CELG)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3900707&HITNO=13&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3900707&THISHREF=http://c.moreover.com/click/here.pl%3fz2463990481%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3900707&HITNO=13&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3900707&THISHREF=http://c.moreover.com/click/here.pl%3fz2463990481%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: News and FDA Updates for Alcon (NYSE:ACL), Biogen (NASDAQ:BIIB), Celgene (NASDAQ:CELG)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3899995&HITNO=14&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3899995&THISHREF=http://c.moreover.com/click/here.pl%3fz2463671819%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3899995&HITNO=14&MSIZE=47&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inbios%20srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3899995&THISHREF=http://c.moreover.com/click/here.pl%3fz2463671819%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Chronicle: